[USE OF LAURYL SULFATE OF THE PROPIONIC ESTER OF ERYTHROMYCIN IN THE ORAL TREATMENT OF EARLY SYPHILIS AND OF CHANCROID].
D035843:Biomedical Research; D002602:Chancroid; D003141:Communicable Diseases; D004917:Erythromycin; D005260:Female; D006801:Humans; D008219:Lymphogranuloma Venereum; D010019:Osteomyelitis; D010874:Pinta; D011247:Pregnancy; D011248:Pregnancy Complications; D011251:Pregnancy Complications, Infectious; D012967:Sodium Dodecyl Sulfate; D013587:Syphilis; D013588:Syphilis Serodiagnosis; D013590:Syphilis, Congenital; D013977:Tibia; D014116:Toxicology; D014247:Trichomonas Vaginitis
D012967:Sodium Dodecyl Sulfate; D004917:Erythromycin; C028913:dodecyl sulfate
CHANCROID; CLINICAL RESEARCH; ERYTHROMYCIN; LYMPHOGRANULOMA VENEREUM; OSTEOMYELITIS; PINTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYPHILIS; SYPHILIS SERODIAGNOSIS; SYPHILIS, CONGENITAL; TIBIA; TOXICOLOGIC REPORT; TRICHOMONAS VAGINITIS
USO DEL LAURIL SULFATO DEL ESTER PROPI'ONICO DE ERITROMICINA EN EL TRATAMIENTO ORAL DE LA S'IFILIS PRECOZ Y CHANCROIDE.